Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'pharmacovigilance' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 123 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Shakir, S; Pearce, G; Mann, RD
      Finasteride and tamsulosin used in benign prostatic hypertrophy: a review of the prescription-event monitoring data

      BJU INTERNATIONAL
    2. Figueiras, A; Tato, F; Fontainas, J; Takkouche, B; Gestal-Otero, JJ
      Physicians' attitudes towards voluntary reporting of adverse drug events

      JOURNAL OF EVALUATION IN CLINICAL PRACTICE
    3. Bortnichak, EA; Wise, RP; Salive, ME; Tilson, HH
      Proactive safety surveillance

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    4. van Puijenbroek, EP; Egberts, ACG; Meyboom, RHB; Leufkens, HGM
      Association between terbinafine and arthralgia, fever and urticaria: symptoms or syndrome?

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    5. Waller, P
      Pharmacoepidemiology - a tool for public health

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    6. Balkrishnan, R; Furberg, CD
      Developing an optimal approach to global drug safety

      JOURNAL OF INTERNAL MEDICINE
    7. Diemont, W; MacKenzie, M; Sxhaap, N; Goverde, G; van Heereveld, H; Hekster, Y; van Grootheest, K
      Neuropsychiatric symptoms during cefepime treatment

      PHARMACY WORLD & SCIENCE
    8. Allain, H; Schuck, S; Mauduit, N; Djemai, M
      Comparative effects of pharmacotherapy on the maintenance of cognitive function

      EUROPEAN PSYCHIATRY
    9. Lindquist, M; Edwards, IR
      The WHO Programme for International Drug Monitoring, its database, and thetechnical support of the Uppsala Monitoring Center

      JOURNAL OF RHEUMATOLOGY
    10. van Puijenbroek, EP; van Grootheest, K; Diemont, WL; Leufkens, HGM; Egberts, ACG
      Determinants of signal selection in a spontaneous reporting system for adverse drug reactions

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    11. Cox, AR; Anton, C; Goh, CHF; Easter, M; Langford, NJ; Ferner, RE
      Adverse drug reactions in patients admitted to hospital identified by discharge ICD-10 codes and by spontaneous reports

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    12. Schneeweiss, S; Gottler, M; Hasford, J; Swoboda, W; Hippius, M; Hoffmann, AK; Riethling, AK; Krappweis, J
      First results from an intensified monitoring system to estimate drug related hospital admissions

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    13. Arnaiz, JA; Carne, X; Codina, C; Ribas, J; Trilla, A
      The use of evidence in pharmacovigilance - Case reports as the reference source for drug withdrawals

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    14. Swoboda, WJ; Gottler, M; Zinnhobler, K; Hasford, J
      Putting the pieces together: Using "off-the-shelf" software to safely transfer medical data

      METHODS OF INFORMATION IN MEDICINE
    15. Koster, MC; Teeuw, B; Cockburn, I
      Compliance in European pharmacovigilance: How compliant is compliant?

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    16. Brown, EG; Douglas, S
      Tabulation and analysis of pharmacovigilance data using the medical dictionary for regulatory activities

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    17. Farah, MH; Edwards, R; Lindquist, M; Leon, C; Shaw, D
      International monitoring of adverse health effects associated with herbal medicines

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    18. Ball, DE
      Evaluation of a training course on pharmacovigilance in sub-Saharan Africa

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    19. Dessing, RP
      Ethics applied to pharmacy practice

      PHARMACY WORLD & SCIENCE
    20. Morales-Olivas, FJ; Martinez-Mir, I; Ferrer, JM; Rubio, E; Palop, V
      Adverse drug reactions in children reported by means of the yellow card inSpain

      JOURNAL OF CLINICAL EPIDEMIOLOGY
    21. Montastruc, JL; Chaumerliac, C; Desboeuf, K; Manika, M; Bagheri, H; Rascol, O; Lapeyre-Mestre, M
      Adverse drug reactions to selegiline: A review of the French Pharmacovigilance Database

      CLINICAL NEUROPHARMACOLOGY
    22. Millson, D; Frischer, M; Croft, P; Goadsby, PJ
      Are triptans with enhanced lipophilicity used for the acute treatment of migraine associated with an increased consulting rate for depressive illness?

      CEPHALALGIA
    23. McMahon, AD; MacDonald, TM
      Design issues for drug epidemiology

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    24. Martin, RM; Dunn, NR; Freemantle, S; Shakir, S
      The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    25. Ford, GA; Wood, SM; Daly, AK
      CYP2D6 and CYP2C19 genotypes of patients with terodiline cardiotoxicity identified through the yellow card system

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    26. Eland, IA; Alvarez, CH; Stricker, BHC; Rodriguez, LAG
      The risk of acute pancreatitis associated with acid-suppressing drugs

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    27. Dunn, NR; Pearce, GL; Shakir, SAW
      Adverse effects associated with the use of donepezil in general practice in England

      JOURNAL OF PSYCHOPHARMACOLOGY
    28. Lindquist, M; Stahl, M; Bate, A; Edwards, IR; Meyboom, RHB
      A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO International Database

      DRUG SAFETY
    29. Meyboom, RHB; Lindquist, M; Egberts, ACG
      An ABC of drug-related problems

      DRUG SAFETY
    30. Pelagatti, V; Bagheri, H; Fernandez, P; Railhac, N; Bregeon, C; Railhac, JJ; Montastruc, JL
      Adverse drug effects of iodinated contrast agents: a six-month study in a radiology department

      THERAPIE
    31. Remy, N; Lapeyre-Mestre, M; Bareille, MP; Bagheri, H; Montastruc, JL
      Drug interactions: a prospective pilot study in primary health care

      THERAPIE
    32. Roch-Torreilles, I; Camu, W; Hillaire-Buys, D
      Safety profile of riluzole (Rilutek (R)) in the treatment of amyotrophic lateral sclerosis

      THERAPIE
    33. Larousse, C; Veyrac, G
      Clinical data with COX-1 and COX-2 inhibitors: what possible alerts in pharmacovigilance?

      THERAPIE
    34. Begaud, B; Dangoumau, J
      Pharmacoepidemiology: definition, difficulties, methodology

      THERAPIE
    35. van Puijenbroek, EP; Egberts, ACG; Heerdink, ER; Leufkens, HGM
      Detecting drug-drug interactions using a database for spontaneous adverse drug reactions: an example with diuretics and non-steroidal anti-inflammatory drugs

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    36. Carne, X; Arnaiz, JA
      Methodological and political issues in clinical pharmacology research by the year 2000

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    37. Biffignandi, PM; Bilia, AR
      The growing knowledge of St. John's wort (Hypericum perforatum L) drug interactions and their clinical significance

      CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
    38. Spreux, A; Baldin, B; Chichmanian, RM
      The pharmacovigilance system in practice

      TRANSFUSION CLINIQUE ET BIOLOGIQUE
    39. Sinclair, HK; Bond, CM; Hannaford, PC
      Pharmacovigilance of over-the-counter products based in community pharmacy: A feasible option?

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    40. Waller, PC; Lee, EH
      Responding to drug safety issues

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    41. Kubota, K
      A design for Prescription-Event Monitoring in Japan (J-PEM)

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    42. Mackay, FJ; Pearce, GL; Freemantle, SN; Mann, RD
      Nefazodone in community use: The results of prescription-event monitoring

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    43. Martin, RM; Wilton, LV; Mann, RD
      Prevalence of Churg-Strauss syndrome, vasculitis, eosinophilia and associated conditions: Retrospective analysis of 58 prescription-event monitoring cohort studies

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    44. Amery, WK
      Why there is a need for pharmacovigilance

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    45. Lindquist, M; Edwards, IR; Bate, A; Fucik, H; Nunes, AM; Stahl, M
      From association to alert - A revised approach to international signal analysis

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    46. Czeizel, AE
      The role of pharmacoepidemiology in pharmacovigilance: Rational drug use in pregnancy

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    47. Meyboom, RHB; Brodie-Meijer, CCE; Diemont, WL; Van Puijenbroek, EP
      Bladder dysfunction during the use of tramadol

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    48. Cutroneo, P; Greco, S; Cucinotta, G; Arcoraci, V; Caputi, AP
      Spontaneous reporting of adverse drug reactions in elderly patients in Sicily (Italy)

      PHARMACOLOGICAL RESEARCH
    49. Mann, RD; Mackay, F; Pearce, G; Freemantle, S; Wilton, LV
      Losartan: a study of pharmacovigilance data on 14 522 patients

      JOURNAL OF HUMAN HYPERTENSION
    50. O'Quinn, S; Ephross, SA; Williams, V; Davis, RL; Gutterman, DL; Fox, AW
      Pregnancy and perinatal outcomes in migraineurs using sumatriptan: a prospective study

      ARCHIVES OF GYNECOLOGY AND OBSTETRICS
    51. O'Quinn, S; Davis, RL; Gutterman, DL; Pait, GD; Fox, AW
      Prospective large-scale study of the tolerability of subcutaneous sumatriptan injection for acute treatment of migraine

      CEPHALALGIA
    52. Naldi, L; Conforti, A; Venegoni, M; Troncon, MG; Caputi, A; Ghiotto, E; Cocci, A; Moretti, U; Velo, G; Leone, R
      Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    53. Edwards, IR
      Spontaneous reporting - of what? Clinical concerns about drugs

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    54. van Puijenbroek, EP; Egberts, ACG; Meyboom, RHB; Leufkens, HGM
      Signalling possible drug-drug interactions in a spontaneous reporting system: delay of withdrawal bleeding during concomitant use of oral contraceptives and itraconazole

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    55. Pierfitte, C; Begaud, B; Lagnaoui, R; Moore, ND
      Is reporting rate a good predictor of risks associated with drugs?

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    56. Evans, JMM; MacDonald, TM
      Record-linkage for pharmacovigilance in Scotland

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    57. Schuck, S; Bentue-Ferrer, D; Beaufils, C; Polard, E; Belliard, S; Allain, H
      Side-effects and drugs for Alzheimer's disease

      THERAPIE
    58. Bagheri, H; Cismondo, S; Montastruc, JL
      Drug-induced hiccup: a review of the French pharmacovigilance database

      THERAPIE
    59. van den Bemt, PMLA; Egberts, ACG; Lenderink, AW; Verzijl, JM; Simons, KA; van der Pol, WSCJM; Leufkens, HGM
      Adverse drug events in hospitalized patients - A comparison of doctors, nurses and patients as sources of reports

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    60. Figueiras, A; Tato, F; Fontainas, J; Gestal-Otero, JJ
      Influence of physicians' attitudes on reporting adverse drug events - A case-control study

      MEDICAL CARE
    61. DOMINE D; GUILLON C; DEVILLERS J; LACROIX R; LACROIX J; DORE JC
      NONLINEAR NEURAL MAPPING ANALYSIS OF THE ADVERSE-EFFECTS OF DRUGS

      SAR and QSAR in environmental research (Print)
    62. ARNOLD GJ
      CLINICAL RECOGNITION OF ADVERSE DRUG-REACTIONS - OBSTACLES AND OPPORTUNITIES FOR THE NURSING PROFESSION

      Journal of nursing care quality
    63. TUBERTBITTER P; HARAMBURU F; BEGAUD B; CHASLERIE A; ABRAHAM E; HAGRY C
      SPONTANEOUS REPORTING OF ADVERSE DRUG-REACTIONS - WHO REPORTS AND WHAT

      Pharmacoepidemiology and drug safety
    64. MAISTRELLO M; MORGUTTI M; ROSSIGNOLI A; POSCA M
      A SELECTIVE GUIDE TO PHARMACOVIGILANCE RESOURCES ON THE INTERNET

      Pharmacoepidemiology and drug safety
    65. WILTON LV; FREEMANTLE SN; MARTIN R; MANN RD
      IS THE INCIDENCE OF UPPER RESPIRATORY-TRACT INFECTION INDEPENDENT OF DRUG-TREATMENT IN LARGE COHORT STUDIES OF LONGER TERM USE DRUGS

      Pharmacoepidemiology and drug safety
    66. ZENUT M; FIALIP J; LAVARENNE J
      EDUCATIONAL INTEREST OF SYSTEMATIC COLLECTION OF ADVERSE DRUG-REACTIONS (WITH REGARD TO AN EXPERIENCE OF NEARLY 20 YEARS)

      Pharmacoepidemiology and drug safety
    67. GRIFFIN JP
      THE EVOLUTION OF HUMAN MEDICINES CONTROL FROM A NATIONAL TO AN INTERNATIONAL PERSPECTIVE

      Adverse drug reactions and toxicological reviews
    68. HOFFMANN A; HIPPIUS M; SICKER T
      ADVERSE DRUG REACTION MONITORING IN JENA - EXPERIENCES OF A REGIONALIZED PHARMACOVIGILANCE CENTER

      Experimental and toxicologic pathology
    69. NEUTEL I
      BENZODIAZEPINE-RELATED TRAFFIC ACCIDENTS IN YOUNG AND ELDERLY DRIVERS

      Human psychopharmacology
    70. MANN RD
      PRESCRIPTION-EVENT MONITORING - RECENT PROGRESS AND FUTURE HORIZONS

      British journal of clinical pharmacology
    71. RODRIGUEZ LAG; GUTTHANN SP
      USE OF THE UK GENERAL-PRACTICE RESEARCH DATABASE FOR PHARMACOEPIDEMIOLOGY

      British journal of clinical pharmacology
    72. TALBOT JCC; NILSSON BS
      PHARMACOVIGILANCE IN THE PHARMACEUTICAL-INDUSTRY

      British journal of clinical pharmacology
    73. Goldman, SA
      Limitations and strengths of spontaneous reports data

      CLINICAL THERAPEUTICS
    74. OLSSON S
      THE ROLE OF THE WHO PROGRAM ON INTERNATIONAL DRUG-MONITORING IN COORDINATING WORLDWIDE DRUG SAFETY EFFORTS

      Drug safety
    75. BAUDOUX E; MARGRAFF U; COENEN A; JACOBS X; STRIVAY M; LUNGU C; SONDAGTHULL D
      HEMOVIGILANCE - CLINICAL TOLERANCE OF SOLVENT-DETERGENT TREATED PLASMA

      Vox sanguinis
    76. Seyer, D; Dif, C; Balthazard, G; Sciortino, V
      Maintenance treatment with high-dose buprenorphine: have the recommendations been followed?

      THERAPIE
    77. Maze, F; Begaud, B
      French pharmacovigilance: regional differences as a source of efficiency

      THERAPIE
    78. ALVAREZREQUEJO A; CARVAJAL A; BEGAUD B; MORIDE Y; VEGA T; ARIAS LHM
      UNDER-REPORTING OF ADVERSE DRUG-REACTIONS - ESTIMATE BASED ON A SPONTANEOUS REPORTING SCHEME AND A SENTINEL SYSTEM

      European Journal of Clinical Pharmacology
    79. LOUPI E; BAUDARD S; DEBOIS H; PIGNATO F
      RISKS ASSOCIATED WITH VACCINATIONS

      Annales de medecine interne
    80. MACKAY FJ; DUNN NR; WILTON LV; PEARCE GL; FREEMANTLE SN; MANN RD
      A COMPARISON OF FLUVOXAMINE, FLUOXETINE, SERTRALINE AND PAROXETINE EXAMINED BY OBSERVATIONAL COHORT STUDIES

      Pharmacoepidemiology and drug safety
    81. CZARNECKI A; MACIEJCZYK A
      PHARMACOVIGILANCE IN POLAND

      Pharmacoepidemiology and drug safety
    82. BIRIELL C; EDWARDS IR
      REASONS FOR REPORTING ADVERSE DRUG-REACTIONS - SOME THOUGHTS BASED ONAN INTERNATIONAL REVIEW

      Pharmacoepidemiology and drug safety
    83. MANN RD; WILTON LV; PEARCE GL; MACKAY FJ; DUNN NR
      PRESCRIPTION-EVENT MONITORING (PEM) IN 1996 - A METHOD OF NON-INTERVENTIONAL OBSERVATIONAL COHORT PHARMACOVIGILANCE

      Pharmacoepidemiology and drug safety
    84. COSENTINO M; LEONI O; BANFI F; LECCHINI S; FRIGO G
      ATTITUDES TO ADVERSE DRUG REACTION REPORTING BY MEDICAL PRACTITIONERSIN A NORTHERN ITALIAN DISTRICT

      Pharmacological research
    85. DEBOCK GH; EELHART J; VANMARWIJK HWJ; TROMP TP; SPRINGER MP
      A POSTMARKETING STUDY OF FLUNARIZINE IN MIGRAINE AND VERTIGO

      Pharmacy world & science
    86. MEYBOOM RHB
      GOOD PRACTICE IN THE POSTMARKETING SURVEILLANCE OF MEDICINES

      Pharmacy world & science
    87. MORIDE Y; HARAMBURU F; REQUEJO AA; BEGAUD B
      UNDER-REPORTING OF ADVERSE DRUG-REACTIONS IN GENERAL-PRACTICE

      British journal of clinical pharmacology
    88. VIAL T; NICOLAS B; DESCOTES J
      DRUG-INDUCED AUTOIMMUNITY - EXPERIENCE OF THE FRENCH PHARMACOVIGILANCE SYSTEM

      Toxicology
    89. VANBOXTEL CJ; WANG G
      SOME OBSERVATIONS ON PHARMACOEPIDEMIOLOGY IN EUROPE

      Netherlands journal of medicine
    90. PHILIPS E; BAUMAN C
      SAFETY SURVEILLANCE OF ESTERIFIED ESTROGENS METHYLTESTOSTERONE (ESTRATEST(R) AND ESTRATEST(R) HS) REPLACEMENT THERAPY IN THE UNITED-STATES

      Clinical therapeutics
    91. BAUMANN P; VLATKOVIC D; MACCIARDI F
      INTOXICATION WITH DEXTROMETHORPHAN IN AN ADOLESCENT WITH A GENETIC CYTOCHROME-P450 CYP2D6 DEFICIENCY

      Therapie
    92. EDWARDS IR
      WHO CARES ABOUT PHARMACOVIGILANCE

      European Journal of Clinical Pharmacology
    93. WAGER E; TOOLEY PJH; PEARCE GL; WILTON LV; MANN RD
      A COMPARISON OF 2 COHORT STUDIES EVALUATING THE SAFETY OF CISAPRIDE -PRESCRIPTION-EVENT MONITORING AND A LARGE PHASE-IV STUDY

      European Journal of Clinical Pharmacology
    94. JOUGLARD J; HAMEL JD; JUVIN P
      A PHARMACOEPIDEMIOLOGIC STUDY OF TRANDOLAPRIL

      Current therapeutic research
    95. KRAFT K; LOEW D; SCHNEIDER B; KEMPER FH
      PLANNING, REALIZATION AND EVALUATION OF P OST-MARKETING-SURVEILLANCE STUDIES - RECOMMENDATIONS OF THE GESELLSCHAFT-FUR-PHYTOTHERAPIE (GPHY)

      Arzneimittel-Forschung
    96. DOWER M
      PHARMACOVIGILANCE - SHOULD THE EXPERTS AGREE TO DIFFER

      Adverse drug reactions and toxicological reviews
    97. HOUGHTON JE; PEREIRA LMP; WOODS FJ; RICHENS A; ROUTLEDGE PA
      THE WELSH ADVERSE DRUG-REACTIONS SCHEME - EXPERIENCE OF A UK REGIONALMONITORING CENTER

      Adverse drug reactions and toxicological reviews
    98. MANN RD; KUBOTA K; PEARCE G; WILTON L
      SALMETEROL - A STUDY BY PRESCRIPTION-EVENT MONITORING IN A UK COHORT OF 15,407 PATIENTS

      Journal of clinical epidemiology
    99. TUBERTBITTER P; BEGAUD B; MORIDE Y; CHASLERIE A; HARAMBURU F
      COMPARING THE TOXICITY OF 2 DRUGS IN THE FRAMEWORK OF SPONTANEOUS REPORTING - A CONFIDENCE-INTERVAL APPROACH

      Journal of clinical epidemiology
    100. WILTON LV; PEARCE GL; MANN RD
      A COMPARISON OF CIPROFLOXACIN, NORFLOXACIN, OFLOXACIN, AZITHROMYCIN AND CEFIXIME EXAMINED BY OBSERVATIONAL COHORT STUDIES

      British journal of clinical pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/05/20 alle ore 22:59:36